Deletion of atypical chemokine receptor 3 (ACKR3) increases immune cells at the fetal-maternal interface

• Published in: Placenta (Eastbourne) 2020-06, Vol.95, p.18-25
• Main Authors: Quinn, Kelsey E., Matson, Brooke C., Caron, Kathleen M.
• Format: Article
• Language: English
• Subjects: Chemokines; Decoy receptors; Immune cells; Placenta
• ISSN: 0143-4004; 1532-3102
• DOI: 10.1016/j.placenta.2020.04.007

Establishment of immune cell populations and adaptations in immune cells are critical aspects during pregnancy that lead to protection of the semi-allogenic fetus. Appropriate immune cell activation and trophoblast migration are regulated in part by chemokines, the availability of which can be fine-tuned by decoy receptors. Atypical chemokine receptor 3 (ACKR3), previously named C-X-C chemokine receptor 7 (CXCR7), is a chemokine decoy receptor expressed in placenta, but little is known about how this receptor affects placental development. In this study, we investigated the phenotypic characteristics of placentas from Ackr3−/− embryos to determine how Ackr3 contributes to early placentation. In placentas from Ackr3−/− embryos, we observed an increase in decidual compaction and in the size of the uterine natural killer cell population. Ackr3 knockdown in trophoblast cells led to a decrease in trophoblast migration. These findings suggest that this decoy receptor may therefore be an important factor in normal placentation. •Investigation of phenotypic characteristics of placentas from embryos with deletion of the decoy receptor, ACKR3.•Fetal-derived Ackr3 contributes to immune response during placental development.•Trophoblast migration may rely on ACKR3 decoy receptor expression.